Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radical Pleurectomy and Chemotherapy +/- Photodynamic Therapy for Epithelioid Malignant Pleural Mesothelioma
NCT02153229Phase 2Active, not recruiting
- Sponsor
- Abramson Cancer Center
- Start
- Jun 2014
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of porfimer sodium in malignant pleural mesothelioma (MPM), sponsored by Abramson Cancer Center. Started Jun 2014; status: active, not recruiting.
02
Drugs
porfimer sodium
03
Conditions
malignant pleural mesothelioma (MPM)
Beyond the preview
Go deeper on NCT02153229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02153229.